Business Standard

US FDA authorises two Covid boosters targeted at Omicron subvariants

US approves Omicron vaccines from Moderna and BioNTech/Pfizer

Moderna vaccine
Premium

Photo: Shutterstock

Reuters
The US Food and Drug Administration on Wednesday authorised updated COVID-19 booster shots from Pfizer /BioNTech and Moderna that target the dominant BA.4 and BA.5 Omicron subvariants, as the government prepares for a fall vaccination campaign that could begin in a few days.

Both vaccines also include the original version of the virus targeted by all the previous COVID shots.

The FDA authorized the shots for everyone over aged 12 who has had a primary vaccination series and is at least two months out from a previous booster shot, shorter than prior recommended intervals. That marks a shift from the current shots

Disclaimer: No Business Standard Journalist was involved in creation of this content

Topics : Coronavirus

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in